This inventor holds 1 USPTO granted patent. Top assignees: Bayer Aktiengesellschaft, The Broad Institute, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 12,268 
1 out of 486 
Years Active: 2025
Title: Innovations of Stefan Niklaus Gradl in Cancer Treatment
Introduction
Stefan Niklaus Gradl is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of cancer treatment through his innovative research and development of pharmaceutical compounds. His work has the potential to impact the lives of many patients battling cancer.
Latest Patents
Stefan Niklaus Gradl holds 1 patent for his invention titled "Acyl sulfonamides for treating cancer." This patent provides acyl sulfonamide compounds of general formula (I), which are designed to offer new therapeutic options for cancer treatment.
Career Highlights
Throughout his career, Gradl has worked with prominent organizations, including Bayer Aktiengesellschaft and The Broad Institute, Inc. His experience in these esteemed institutions has allowed him to refine his skills and contribute to groundbreaking research in the pharmaceutical industry.
Collaborations
Stefan has collaborated with talented individuals such as Léa Aurelie Bouché and Daniel Korr. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Stefan Niklaus Gradl's work in developing acyl sulfonamides represents a significant advancement in cancer treatment. His contributions to the field highlight the importance of innovation in addressing complex medical challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile